Author: V.Iyengar, Megaphone Editor-in-chief 📍Foster City, CA Intro On December 22, 2022, the FDA approved Lenacapavir— or as it’s known by its brand name, Sunlenca®— a twice-yearly injection meant to prevent HIV infection in adults, declaring that the drug is safe and effective for its intended use. Almost exactly one-and-a-half years later, on June 20th of this year, Foster City’s Gilead Sciences Inc, the company … Continue reading The Future of HIV Prevention: Gilead’s Lenacapavir